Recombinant Mouse IGFBP2 Protein (HEK293)，His

Insulin-like growth factor-binding protein 2 (IGFBP2) has garnered significant attention in biomedical research due to its pivotal role in modulating insulin-like growth factor (IGF) activity, which is crucial for cell growth, development, and metabolism. IGFBP2 acts by binding to IGFs, thereby extending their half-life and regulating their bioavailability, a mechanism that is vital for both normal physiological processes and various pathological conditions. Elevated levels of IGFBP2 have been associated with several malignancies, including breast and colorectal cancers, where it may facilitate tumor progression and metastasis. Additionally, IGFBP2 is implicated in metabolic disorders such as obesity and type 2 diabetes, given its influence on insulin signaling pathways. The production of recombinant IGFBP2 has enabled researchers to investigate its biochemical properties, affinities, and mechanisms of action in detail, providing insights into its role in cancer biology and metabolic regulation. Understanding the functions of IGFBP2 at the molecular level may pave the way for novel therapeutic strategies targeting the IGF signaling pathway. As such, investigations into recombinant IGFBP2 are not only fundamental for elucidating its biological functions but also hold potential for clinical applications in cancer therapy and metabolic disease management.